PaxMedica, Inc（PXMD）美股招股说明书 S-1 （2022-01-04修订版）（英文版）（162页）.pdf

1、Large accelerated filerAccelerated filerNon-accelerated filerSmaller reporting companyEmerging growth company(1)(2)(3)S-1/A 1 tm2135343-1_s1a.htm S-1/ATABLE OF CONTENTSAs filed with the Securities and Exchange Commission on January 4,2022.Registration No.333-239676 UNITED STATESSECURITIES AND EXCHAN

2、GE COMMISSIONWashington,D.C.20549 Amendment No.7toFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 PAXMEDICA,INC.(Exact name of registrant as specified in its charter)Delaware(State or other jurisdiction ofincorporation or organization)2834(Primary Standard IndustrialClassification Code

3、 Number)85-0870387(I.R.S.EmployerIdentification No.)303 South Broadway,Suite 125Tarrytown,NY 10591914-987-2876(Address,including zip code,and telephone number,including area code,of registrants principal executive offices)Howard J.WeismanChief Executive OfficerPaxMedica,Inc.303 South Broadway,Suite

4、125Tarrytown,NY 10591Tel:914-987-2876(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies to:David S.Rosenthal,Esq.Anna Tomczyk,Esq.Dechert LLP1095 Avenue of the AmericasNew York,NY 10036Telephone:(212)698-3500 Joseph Lucosky,Esq.Lucosky Brookman LLP1

5、01 Wood Avenue SouthWoodbridge,NJ 08830Telephone:(732)395-4400 Approximate date of commencement of proposed sale to the public:As soon as practicable after this registration statement becomes effective.If any of the securities being registered on this Form are to be offered on a delayed or continuou

6、s basis pursuant to Rule 415 under the SecuritiesAct of 1933 check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please check the followingbox and list the Securities Act registration statement number of the